53995-67-8

Basic information

• Product Name: 2,3-diamino-4-methyl-thiazolium; 2,4,6-trimethyl-benzenesulfonate
• CAS NO: 53995-67-8
• Molecular Weight: 329.444
• Mol File: 53995-67-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 2,3-diamino-4-methyl-thiazolium; 2,4,6-trimethyl-benzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-diamino-4-methyl-thiazolium; 2,4,6-trimethyl-benzenesulfonate(53995-67-8)
• EPA Substance Registry System: 2,3-diamino-4-methyl-thiazolium; 2,4,6-trimethyl-benzenesulfonate(53995-67-8)

Safety Data

• Hazardous Substances Data: 53995-67-8(Hazardous Substances Data)

Upstream product

• 1603-91-4 4-methylthiazol-2-ylamine 
• 36016-40-7 mesitylenesulfonylhydroxylamine 

Relevant articles and documents

Thiazolo[3,2 b] s triazole

-

Method and composition for rejuvenating hair, nails, tissues, cells and organs by ex-vivo or immersive treatment

A method and composition for the treatment of hair, nail, ex-vivo organ, ex-vivo cell or ex-vivo tissue to improve the biomechanical and diffusional characteristics comprising an effective amount of a compound selected from the group consisting of compounds of the formula

Preventing and reversing the formation of advanced glycosylation endproducts

The present invention relates to compositions and methods for inhibiting and reversing nonenzymatic cross-linking (protein aging). Accordingly, compositions are disclosed which comprise an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins, and which additionally reverse pre-formed crosslinks in the advanced glycosylation endproducts by cleaving alpha-dicarbonyl-based protein crosslinks present in the advanced glycosylation endproducts. Certain agents useful are thiazolium salts. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated. A novel immunoassay for detection of the reversal of the nonenzymatic crosslinking is also disclosed.